CRYPTOCOCCAL MENINGITIS
Clinical trials for CRYPTOCOCCAL MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new CRYPTOCOCCAL MENINGITIS trials appear
Sign up with your email to follow new studies for CRYPTOCOCCAL MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Dose wonder: could a single shot stop a deadly brain infection in HIV patients?
Disease control Recruiting nowThis study looks at whether giving a single, stronger dose of antifungal medicine (liposomal amphotericin) plus standard fluconazole can prevent cryptococcal meningitis in HIV-positive people who test positive for the fungus but have no symptoms. About 356 participants in Uganda …
Matched conditions: CRYPTOCOCCAL MENINGITIS
Phase: PHASE2, PHASE3 • Sponsor: Makerere University • Aim: Disease control
Last updated May 16, 2026 22:35 UTC
-
New hope against a 100% fatal brain infection: massive trial launches
Disease control Recruiting nowThis study tests new drug combinations for cryptococcal meningitis, a brain infection that is always fatal without treatment and still kills many people with HIV. The trial aims to find safer, more effective therapies that are easier to access worldwide. About 2,000 adults with H…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Phase: PHASE2, PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Healthy adults with rare fungal infection sought for landmark study
Knowledge-focused Recruiting nowThis study aims to learn more about cryptococcosis, a fungal infection, in adults who were previously healthy and have no known immune problems. Researchers will collect medical records and samples from 800 participants to understand the full range of symptoms, how the immune sys…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Scientists track rare immune condition to uncover its secrets
Knowledge-focused Recruiting nowThis study aims to learn more about idiopathic CD4+ lymphocytopenia (ICL), a rare condition where the body has too few CD4+ immune cells, leading to infections or autoimmune problems. Researchers will follow about 950 participants for up to 10 years, collecting medical history, b…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC